Caris Life Sciences (CAI) Short-term Investments (2024 - 2026)

Caris Life Sciences' Short-term Investments history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Short-term Investments changed N/A year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 53.82% from the prior year.
• Short-term Investments was $2.3 million for Q1 2026 at Caris Life Sciences, up from $2.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $2.3 million in Q1 2026 to a low of $1.5 million in Q4 2024.
• Historically, Short-term Investments has averaged $2.1 million across 3 years, with a median of $2.3 million in 2025.
• Biggest YoY gain for Short-term Investments was 53.82% in 2025; the steepest drop was 53.82% in 2025.
• A 3-year view of Short-term Investments shows it stood at $1.5 million in 2024, then surged by 53.82% to $2.3 million in 2025, then rose by 0.87% to $2.3 million in 2026.
• The last three Short-term Investments figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.